HER2-CAR T Cells in Treating Participants With Brain or Leptomeningeal Metastases
Conditions: HER2/Neu Positive; Malignant Neoplasm; Metastatic Malignant Neoplasm in the Brain; Metastatic Malignant Neoplasm in the Leptomeninges Intervention: Biological: Chimeric Antigen Receptor T-Cell Therapy Sponsors: City of Hope Medical Center; National Cancer Institute (NCI) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials